COMMUNIQUÉS West-GlobeNewswire

Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
24/04/2026
Webcast scheduled for Monday, April 27, 2026 at 8:00am ET. BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing [...]
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
24/04/2026
Ruling preserves current contracted royalty rates and rejects Tesaro’s request for any royalty reduction Trial to adjudicate Anaptys’ contract claims and right to seek reversion of Jemperli against Tesaro/GSK is [...]
ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026
24/04/2026
Healthcare products company unveils new brand identity and introduces Silkura, a revolutionary silicone-based ostomy pouch BERLIN, April 24, 2026 (GLOBE NEWSWIRE) -- ForLife Produktions- und Vertriebsgesellschaft für [...]
Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill
24/04/2026
Brooklyn biotech files 40-claim patent application covering a new active-ingredient combination for over-the-counter headache relief NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Plopii , a Brooklyn-based biotechnology [...]
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
24/04/2026
Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders White Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- President [...]
Press Release: Sanofi successfully prices 2.3 billion of bond issue
24/04/2026
Sanofi successfully prices 2.3 billion of bond issue Paris, April 24, 2026 - Sanofi announces that it has successfully priced its offering of €2.3 billion of notes across 3 tranches: €1,000 million fixed-rate notes, due [...]
Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires
24/04/2026
Sanofi place 2,3 milliard d’euros d’emprunts obligataires Paris, 24 avril 2026 - Sanofi annonce avoir placé avec succès une émission obligataire en 3 tranches (les « obligations ») pour un montant de 2,3 milliards d’ [...]
Financière de Tubize - Dividend approval
24/04/2026
Dividend confirmation Regulated information - 24 April 2026 The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of a gross dividend of € [...]
Financière de Tubize - Approbation du dividende
24/04/2026
Approbation du dividende Information réglementée - 24 avril 2026 L’assemblée générale des actionnaires du 24 avril 2026 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31 décembre 2025, en ce [...]
KFSH Scales Genomic Medicine from Research to Clinical Decision-Making
24/04/2026
RIYADH, Saudi Arabia, April 24, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is advancing a clinically integrated model of genomic medicine, demonstrating how large-scale genetic [...]
Metabo Drops 2026 | Launch "Tasteless Drop Effective Weight Loss Turns Any Coffee Into Boosted Metabolism Explained Fat Burning Supplement MetaboDrops
24/04/2026
Metabo Drops 2026 New tasteless liquid drops designed to support weight loss by turning any coffee into a metabolism-boosting drink for enhanced fat burning, energy support, and easier daily routine with consistent use [...]
Acentra Health Chief AI Officer Sean Harrison Named to NVTC AI50
24/04/2026
Inaugural Award Highlights Executive and Company Dedication to AI Innovation in Northern Virginia Region MCLEAN, Va., April 24, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company [...]
ACTG Launches Landmark Study Evaluating Treatments for Depressive Disorders with or without Mild Neurocognitive Disorder among People Living with HIV
24/04/2026
CHAPEL HILL, N.C., April 24, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of study A5402, an important new study that [...]
The Genius Song & The Brain Song Official 2026: 7-Second Brain Trick’ Genius Brainwave Music to Improve Focus and memory By Genius wave?
24/04/2026
The Genius Song Claims Evaluated Latest 2026 "7-Second Brain Trick" Read Report on Gamma Wave Audio Marketing, Consumer Report, Pricing, and What Consumers Should Verify New York City, April 24, 2026 (GLOBE NEWSWIRE [...]
A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform
24/04/2026
Pioneering Biosecurity for Genomic Data TOKYO, April 24, 2026 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare Co.) today announced GeneLock™, a new genomic security platform [...]
Resolutions of the Annual General Meeting
24/04/2026
April 24, 2026 Announcement no. 10 Resolutions of the Annual General Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 24, 2026, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH: BIOPOR), an in vitro [...]
DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration
24/04/2026
TOKYO, April 24, 2026 (GLOBE NEWSWIRE) -- In celebration of DNA DAY™, A.D.A.M. Innovations Co. (Japanese corporate name Genesis Healthcare Co.) today announced a major update to GeneLife GeneAI Forecast, expanding the [...]
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/04/2026
SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through [...]
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
24/04/2026
A collaboration with Virginia Tech supports recognizing remission as a treatment outcome—capturing symptoms, quality of life, and functional outcomes—beyond abstinence alone Of all MOUD, monthly extended-release [...]

Pages